Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Niagen Bioscience Inc (NASDAQ: NAGE) closed at $13.41 down -5.10% from its previous closing price of $14.13. In other words, the price has decreased by -$5.10 from its previous closing price. On the day, 0.74 million shares were traded. NAGE stock price reached its highest trading level at $14.2969 during the session, while it also had its lowest trading level at $13.4.
Ratios:
For a deeper understanding of Niagen Bioscience Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 54.17. For the most recent quarter (mrq), Quick Ratio is recorded 3.12 and its Current Ratio is at 3.66. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on May 27, 2025, initiated with a Buy rating and assigned the stock a target price of $13.
B. Riley Securities Downgraded its Buy to Neutral on August 11, 2022, whereas the target price for the stock was revised from $6 to $2.40.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 ’25 when Lopez Carlos Luis bought 273 shares for $7.86 per share. The transaction valued at 2,146 led to the insider holds 2,251 shares of the business.
Jaksch Frank L Jr sold 37,161 shares of NAGE for $229,956 on Dec 13 ’24. The Director now owns 244,179 shares after completing the transaction at $6.19 per share. On Dec 13 ’24, another insider, Frank Jaksch Jr., who serves as the affiliate of the company, bought 37,161 shares for $6.19 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAGE now has a Market Capitalization of 1056301632 and an Enterprise Value of 1006600640. As of this moment, Niagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 77.65, and their Forward P/E ratio for the next fiscal year is 55.98. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.59. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.79 while its Price-to-Book (P/B) ratio in mrq is 19.00. Its current Enterprise Value per Revenue stands at 9.327 whereas that against EBITDA is 71.787.
Stock Price History:
The Beta on a monthly basis for NAGE is 2.11, which has changed by 4.060377 over the last 52 weeks, in comparison to a change of 0.111126065 over the same period for the S&P500. Over the past 52 weeks, NAGE has reached a high of $14.49, while it has fallen to a 52-week low of $2.31. The 50-Day Moving Average of the stock is 30.33%, while the 200-Day Moving Average is calculated to be 97.53%.
Shares Statistics:
For the past three months, NAGE has traded an average of 867.48K shares per day and 828720 over the past ten days. A total of 78.43M shares are outstanding, with a floating share count of 49.81M. Insiders hold about 36.77% of the company’s shares, while institutions hold 31.85% stake in the company. Shares short for NAGE as of 1748563200 were 2801140 with a Short Ratio of 3.23, compared to 1745971200 on 2461532. Therefore, it implies a Short% of Shares Outstanding of 2801140 and a Short% of Float of 5.41.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
